Validations: Biologics, ATMP & Viral Safety Validation
Assay Validation for Complex CQAs: ICH Q2(R2) Interpretation Assay Validation for Complex CQAs: ICH Q2(R2) Interpretation Assay validation is an essential component in the development and manufacturing of biopharmaceuticals, particularly concerning complex quality attributes (CQAs). Understanding the intricate details of assay validation under ICH Q2(R2) is crucial for ensuring compliance with regulations from the FDA, EMA, and MHRA. This article…
Reference Standards & System Suitability: Controls That Work Reference Standards & System Suitability: Controls That Work In the current landscape of pharmaceutical development, particularly in biologics and advanced therapy medicinal products (ATMP), understanding the implementation and validation of reference standards and system suitability is paramount. This comprehensive guide will offer a step-by-step tutorial on the importance of proper planning, execution…
Matrix Effects and Interferences: Mitigation Strategies Introduction to Matrix Effects and Interferences in Biologics Biopharmaceutical development, particularly within the realms of Advanced Therapy Medicinal Products (ATMP) and other biologics, necessitates a profound understanding of matrix effects and their corresponding interferences. Matrix effects can significantly influence analytical results, especially during viral clearance validation and potency assessments. Understanding and mitigating these interferences…
Assay Variability & Gage R&R: What’s Acceptable Assay Variability & Gage R&R: What’s Acceptable Understanding Assay Variability in Pharmaceutical Validation Assay variability is a crucial concept in the validation of biologics, primarily because it helps in understanding the precision and reliability of analytical methods used in the evaluation of potency and identity of complex quality attributes (CQAs) in Advanced Therapy…
Bridging Assays Across Sites: Equivalence and Bias Bridging Assays Across Sites: Equivalence and Bias In the rapidly evolving realm of pharmaceuticals, particularly within the context of biologics and advanced therapy medicinal products (ATMPs), ensuring consistency and reliability in assay performance across different sites is paramount. This article discusses bridging assays across different clinical sites by emphasizing the importance of equivalence…
Templates: Closed System Qualification Packs Templates: Closed System Qualification Packs The advent of advanced therapeutics and biologics has prompted the pharmaceutical industry to adopt stringent validation frameworks to ensure product safety and efficacy. This step-by-step tutorial focuses on the critical aspects of qualification packs for closed systems, with a particular emphasis on aseptic processing, viral clearance validation, and regulatory compliance…
Templates: Closed System Qualification Packs for Aseptic and Viral Clearance Validation Introduction to Closed Systems in Pharmaceutical Validation Closed systems are essential components in the validation landscape, especially in the development and manufacturing of Advanced Therapy Medicinal Products (ATMPs) and biologics. With increasing regulatory scrutiny surrounding aseptic processing and viral clearance validation, understanding how to qualify these systems has become…
QS for Single-Use: Records and Governance QS for Single-Use: Records and Governance In the increasingly complex landscape of biologics and advanced therapy medicinal products (ATMPs), the necessity for comprehensive quality standards (QS) for single-use systems cannot be overstated. This article serves as a thorough guide to understanding the records and governance surrounding these systems, focusing on key areas such as…
QS for Single-Use: Records and Governance In the evolving landscape of biologics and advanced therapy medicinal products (ATMP), single-use systems have emerged as a critical component enabling manufacturers to address the complexities of aseptic processing. This detailed tutorial provides a comprehensive guide on the governance and record-keeping aspects essential for the validation of these systems, aligning with regulatory expectations from…
Complex CQAs in Biologics/ATMP: Potency, Identity, and Purity Complex CQAs in Biologics/ATMP: Potency, Identity, and Purity As the landscape of biologics and Advanced Therapy Medicinal Products (ATMP) evolves, so does the complexity of their Critical Quality Attributes (CQAs). This article serves as a comprehensive guide for professionals involved in the development and regulation of these complex products, specifically focusing on…